Gurzu Simona, Jung Ioan, Kadar Zoltan
Department of Pathology, University of Medicine and Pharmacy of Tirgu-Mures, Tirgu-Mures, Romania.
Department of Oncology, University of Medicine and Pharmacy of Tirgu-Mures, Tirgu-Mures, Romania.
APMIS. 2015 Dec;123(12):999-1006. doi: 10.1111/apm.12469.
In this paper, we have focused on the metastatic behavior of EGC and its particularities. The main factors that are currently considered as predictors of the metastatic behavior and that are used in the therapeutic decision (endoscopic resection vs surgical removal) are the tumor size (upper or bellow 2 cm), depth of infiltration, angiolymphatic invasion, the presence or absence of ulceration, and histologic type (undifferentiated vs differentiated carcinomas). However, most of the metastatic cases were published as case reports or case series. This is the reason why a proper estimation of metastatic risk in EGC is not well known. To date, 79 cases presenting bone metastases, three reports of brain metastases, and one EGC that was associated with skin metastasis were published. However, occult metastasis, lymph node micrometastasis, and skip metastasis can also occur and should be identified. Making a synthesis of the literature data that is correlated with our experience, we finally proposed the inclusion of the six Japanese subgrouping system, tumor size, angiolymphatic invasion, and micrometastasis as components of the pTNM staging system, which should be particularly adapted for EGC.
在本文中,我们重点关注了早期胃癌(EGC)的转移行为及其特殊性。目前被视为转移行为预测指标并用于治疗决策(内镜切除与手术切除)的主要因素包括肿瘤大小(2 cm以上或以下)、浸润深度、血管淋巴管浸润、有无溃疡以及组织学类型(未分化癌与分化型癌)。然而,大多数转移病例是以病例报告或病例系列的形式发表的。这就是为什么早期胃癌转移风险的准确评估尚不为人所知的原因。迄今为止,已发表了79例出现骨转移的病例、3例脑转移报告以及1例与皮肤转移相关的早期胃癌病例。然而,隐匿性转移、淋巴结微转移和跳跃转移也可能发生,应予以识别。综合与我们经验相关的文献数据,我们最终提议将日本的六分组系统、肿瘤大小、血管淋巴管浸润和微转移纳入pTNM分期系统的组成部分,该分期系统应特别适用于早期胃癌。